7-Bromo-1H-indole-3-carboxylic acid(CAS: 86153-25-5)

7-Bromo-1H-indole-3-carboxylic acid (CAS: 86153-25-5) falls under the scope of the REACH regulation in the European Union and the TSCA in the United States. It is also subject to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for proper hazard communication. In the context of pharmaceuticals, it must comply with FDA regulations regarding chemical structure and toxicity. For environmental protection, it should be managed according to EPA guidelines to prevent contamination.

Alternative reagents for synthesis include 7-iodo-1H-indole-3-carboxylic acid, 7-chloro-1H-indole-3-carboxylic acid, and 7-fluoro-1H-indole-3-carboxylic acid. These bromo-substituted analogs can be used as synthetic equivalents. Additionally, other indole derivatives such as 1H-indole-3-carboxylic acid can serve as useful alternatives depending on the desired properties and reactivity.

The market trend for 7-Bromo-1H-indole-3-carboxylic acid (CAS: 86153-25-5) is driven by its use in pharmaceuticals and research, particularly in the development of bioactive compounds and drug candidates. Recent research focuses on its potential as a scaffold for new drug discovery. Market trends indicate a steady demand with increasing interest in its application for therapeutic purposes.

Waste containing 7-Bromo-1H-indole-3-carboxylic acid (CAS: 86153-25-5) should be collected in appropriate containers and stored in a secure area. It should be treated as a hazardous waste and disposed of through a professional chemical waste disposal service. Environmental precautions include neutralizing any residual bromine compounds and ensuring the waste is not released into the environment. Compliance with local and international regulations for chemical waste disposal is crucial.